Targets SOCS3 and activates IL‐6/STAT3 signaling in HSCs, promotes the CCL20/CCR6/ERK1/2/Elk‐1/miRNA‐181a‐5p positive feedback loop; inhibits SP3 in KCs and releases TGF‐β. Here, SP3 is linked to dry eye syndrome.